INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $903,659 | +85.0% | 48,741 | +10.4% | 0.00% | – |
| Q2 2023 | $488,365 | -58.7% | 44,156 | -49.8% | 0.00% | – |
| Q1 2023 | $1,181,206 | +116.1% | 87,952 | +99.1% | 0.00% | – |
| Q4 2022 | $546,527 | -95.8% | 44,182 | -95.3% | 0.00% | -100.0% |
| Q3 2022 | $13,035,000 | -54.3% | 934,378 | -54.8% | 0.00% | -66.7% |
| Q2 2022 | $28,539,000 | -25.0% | 2,066,506 | -11.6% | 0.00% | 0.0% |
| Q1 2022 | $38,039,000 | -5.8% | 2,337,992 | -5.7% | 0.00% | 0.0% |
| Q4 2021 | $40,380,000 | +6.0% | 2,478,822 | -3.4% | 0.00% | 0.0% |
| Q3 2021 | $38,111,000 | -25.9% | 2,566,430 | -0.4% | 0.00% | -25.0% |
| Q2 2021 | $51,451,000 | -22.3% | 2,576,472 | -10.2% | 0.00% | -33.3% |
| Q1 2021 | $66,218,000 | -23.4% | 2,869,051 | -18.0% | 0.01% | -25.0% |
| Q4 2020 | $86,391,000 | -44.1% | 3,497,611 | -6.2% | 0.01% | -50.0% |
| Q3 2020 | $154,559,000 | -33.1% | 3,727,918 | -22.7% | 0.02% | -36.0% |
| Q2 2020 | $230,989,000 | -24.7% | 4,821,305 | -1.0% | 0.02% | -40.5% |
| Q1 2020 | $306,707,000 | -49.1% | 4,871,464 | +0.3% | 0.04% | -36.4% |
| Q4 2019 | $602,058,000 | +87.0% | 4,858,446 | +0.1% | 0.07% | +69.2% |
| Q3 2019 | $322,037,000 | -16.5% | 4,852,879 | +0.1% | 0.04% | -13.3% |
| Q2 2019 | $385,772,000 | -22.6% | 4,848,216 | +8.9% | 0.04% | -25.0% |
| Q1 2019 | $498,144,000 | +11.1% | 4,453,270 | +0.1% | 0.06% | -1.6% |
| Q4 2018 | $448,331,000 | -20.0% | 4,448,170 | +0.3% | 0.06% | -3.2% |
| Q3 2018 | $560,368,000 | +50.5% | 4,434,702 | -0.1% | 0.06% | +46.5% |
| Q2 2018 | $372,336,000 | +60.3% | 4,437,332 | +17.5% | 0.04% | +53.6% |
| Q1 2018 | $232,286,000 | +5.6% | 3,775,790 | +0.3% | 0.03% | +7.7% |
| Q4 2017 | $219,969,000 | +0.7% | 3,765,300 | +0.0% | 0.03% | 0.0% |
| Q3 2017 | $218,479,000 | -51.9% | 3,764,290 | +0.4% | 0.03% | -53.6% |
| Q2 2017 | $454,094,000 | +7.8% | 3,750,678 | +0.7% | 0.06% | +3.7% |
| Q1 2017 | $421,266,000 | +4.2% | 3,724,720 | +0.1% | 0.05% | 0.0% |
| Q4 2016 | $404,321,000 | -33.8% | 3,721,316 | +0.3% | 0.05% | -33.3% |
| Q3 2016 | $610,457,000 | +15.9% | 3,708,956 | +0.5% | 0.08% | +12.5% |
| Q2 2016 | $526,493,000 | +11.9% | 3,690,024 | +0.8% | 0.07% | +10.8% |
| Q1 2016 | $470,315,000 | -13.7% | 3,660,896 | +0.3% | 0.06% | -11.0% |
| Q4 2015 | $545,087,000 | -9.5% | 3,649,728 | +0.5% | 0.07% | -15.1% |
| Q3 2015 | $602,126,000 | -30.9% | 3,630,324 | +0.5% | 0.09% | -23.2% |
| Q2 2015 | $871,586,000 | -13.7% | 3,610,846 | +0.8% | 0.11% | -13.2% |
| Q1 2015 | $1,010,502,000 | +102.2% | 3,583,086 | +11.8% | 0.13% | +98.5% |
| Q4 2014 | $499,816,000 | -33.7% | 3,203,951 | +0.7% | 0.06% | -36.3% |
| Q3 2014 | $753,312,000 | +0.4% | 3,182,693 | +0.3% | 0.10% | +1.0% |
| Q2 2014 | $750,578,000 | -21.2% | 3,171,948 | +9.8% | 0.10% | -23.5% |
| Q1 2014 | $952,852,000 | +423.8% | 2,889,269 | +8.5% | 0.13% | +407.7% |
| Q4 2013 | $181,897,000 | +11.3% | 2,663,980 | +12.5% | 0.03% | +4.0% |
| Q3 2013 | $163,436,000 | +82.3% | 2,367,621 | +18.4% | 0.02% | +66.7% |
| Q2 2013 | $89,656,000 | – | 1,999,469 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |